These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8400187)

  • 1. [The phenomenon of the enhancement of the formation of lymphocytotoxic alloimmune antibodies during the use of plasmapheresis].
    Zotikov EA; Babaeva AG; Kalinin NN; Vasil'eva MN; Golovkina LL; Shtyreva EM; Mikhaĭlova EA; Biriukova LS
    Biull Eksp Biol Med; 1993 Jul; 116(7):61-3. PubMed ID: 8400187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
    Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.
    Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS
    Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of anti-HLA antibodies eluted from explanted renal allografts.
    Heinemann FM; Roth I; Rebmann V; Arnold ML; Spriewald BM; Grosse-Wilde H
    Clin Transpl; 2006; ():371-8. PubMed ID: 18365391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of serum HLA antigens in allogeneic combinations.
    Pellegrino MA; Indiveri F; Fagiolo U; Antonello A; Ferrone S
    Transplantation; 1982 May; 33(5):530-3. PubMed ID: 6953687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of human recombinant erythropoietin therapy on panel reactive antibodies in chronic dialysis patients.
    Friedlaender MM; Azem O; Rubinger D; Brautbar C
    Isr J Med Sci; 1996 Sep; 32(9):730-6. PubMed ID: 8865827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report.
    Sasaki M; Yagihashi A; Kobayashi D; Watanabe N; Fujikawa T; Chiba S; Sato S; Morishita K; Sekimoto T; Ikeda H
    Pediatr Hematol Oncol; 2001 Dec; 18(8):519-24. PubMed ID: 11764101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
    J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring and treating posttransplant human leukocyte antigen antibodies.
    Everly MJ; Terasaki PI
    Hum Immunol; 2009 Aug; 70(8):655-9. PubMed ID: 19375466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protein A immunoadsorption al a new apheresis procedure for elimination of HLA antibodies].
    Schneidewind J; Gliesche T; Sehland D; Ramlow W; Wolfsdorff B; Bast R; Wegener S; Decker S; Schmidt R
    Beitr Infusionsther Transfusionsmed; 1994; 32():360-5. PubMed ID: 9480125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased lung allograft failure in patients with HLA-specific antibody.
    Girnita AL; McCurry KR; Zeevi A
    Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients].
    Schnaidt M; Wernet D; Mayer G; Northoff H
    Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications.
    Briggs D; Zehnder D; Higgins RM
    Contrib Nephrol; 2009; 162():107-16. PubMed ID: 19001818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody formation after filtered blood cell replacement in hematologic-oncologic patients].
    Barz D; Staack D; Lehmann R; Stange K; Schnurstein K
    Beitr Infusionsther Transfusionsmed; 1996; 33():30-4. PubMed ID: 8974705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.
    Zachary AA; Montgomery RA; Leffell MS
    Hum Immunol; 2005 Apr; 66(4):364-70. PubMed ID: 15866699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen antibodies and chronic rejection: from association to causation.
    Terasaki PI; Cai J
    Transplantation; 2008 Aug; 86(3):377-83. PubMed ID: 18698239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of adsorption methods for plasma component apheresis].
    Bang B; Heegaard NH
    Ugeskr Laeger; 1991 Nov; 153(48):3388-92. PubMed ID: 1957403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.